Esperion Therapeutics, Inc. - Common Stock (ESPR)
3.1100
+1.1100 (55.50%)
NASDAQ · Last Trade: May 3rd, 12:07 PM EDT
What's going on in today's sessionchartmill.com
Via Chartmill · May 1, 2026
US stocks were mixed on Friday, with Dow Jones down 0.1%. Veeva Systems Inc (NYSE: VEEV) rose 11.6%, joining S&P 500 on May 7. Other big gainers: Esperion Therapeutics Inc (NASDAQ: ESPR), Five9 Inc (NASDAQ: FIVN), Pershing Square Inc (NYSE: PS), Lightwave Logic Inc (NASDAQ: LWLG), AXT Inc (NASDAQ: AXTI), SoundHound AI Inc (NASDAQ: SOUN), Applied Optoelectronics Inc (NASDAQ: AAOI), Reddit Inc (NYSE: RDDT), nVent Electric PLC (NYSE: NVT), Nebius Group NV (NASDAQ: NBIS), Paramount Skydance Corp (NASDAQ: PSKY), Encompass Health Corp (NYSE: EHC).
Via Benzinga · May 1, 2026
Friday's session: most active stockschartmill.com
Via Chartmill · May 1, 2026
Which stocks are moving on Friday?chartmill.com
Via Chartmill · May 1, 2026
Esperion Therapeutics Inc (NASDAQ:ESPR) Reports Mixed Q4 2025 Results Amid Strategic Expansionchartmill.com
Via Chartmill · March 10, 2026
Why Is Esperion Therapeutics Stock Sinking Premarket Today?stocktwits.com
Via Stocktwits · October 8, 2025
Esperion Shares Rally After Patent Litigation Settlement For Cholesterol Drugsstocktwits.com
Via Stocktwits · October 3, 2025
Let's uncover which stocks are experiencing notable gaps during today's session.chartmill.com
Via Chartmill · May 1, 2026
Stay updated with the stocks that are on the move in today's pre-market session.chartmill.com
Via Chartmill · May 1, 2026
Esperion reported earnings per share of $0.22 on revenue of $168.5 million, while Wall Street expected an EPS of $0.28 on revenue of $164.7 million.
Via Stocktwits · March 10, 2026
Piper Sandler projected long-term growth backed by rising use of Esperion’s LDL-lowering therapies and expanding payer coverage.
Via Stocktwits · November 25, 2025
Via Benzinga · November 6, 2025
Esperion's Q3 2025 shows strong revenue growth beating estimates, but a deeper loss led to a sharp stock sell-off. The company secured key patents and targets profitability in 2026.
Via Chartmill · November 6, 2025
Via Benzinga · November 6, 2025
Via Benzinga · November 6, 2025
Via Benzinga · October 8, 2025
Via Benzinga · October 8, 2025
Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.
Via Chartmill · October 8, 2025
Via Benzinga · October 8, 2025
Via Benzinga · October 8, 2025
Via Benzinga · October 8, 2025
Via Benzinga · October 7, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via Chartmill · October 7, 2025
